Yield

Yield

Penumbra generates cash, but not on a scale the price respects. On the framework's basis — reported free cash flow minus stock-based compensation minus the five-year average of cash acquisitions — adjusted FCF was $115.7M in FY2025, a 0.92% yield on the $12.6B market cap. The balance sheet is a fortress (no funded debt), which sets the reference line at roughly 8–9%; the current yield sits about 710–810 bps below it. Consensus forward FCF reaches only ~2.4% by FY2028. There is no path to the bar.

The adjustment, line by line

Reported free cash flow is operating cash flow less purchases of property and equipment. From it the framework removes stock-based compensation (a real, recurring cost that FCF adds back) and the trailing five-year average of cash spent on acquisitions. Penumbra's acquisitions have been paid in stock, not cash — the 2021 purchase that folded in its immersive-rehabilitation business was settled with $174.1M of common stock and $80.7M of replacement options [1], non-cash consideration that never touches the cash-flow adjustment but does inflate the share count. Cash acquisition outlays across the window are immaterial (a $1.0M asset acquisition in FY2023, sub-$2M acquisition-obligation payments in FY2019–FY2020), so the five-year average rounds to zero.

Adjusted FCF = reported FCF − SBC − 5-yr avg cash acquisitions; derived from company filings. SBC from the Consolidated Statements of Cash Flows: FY2025/24/23 [2], FY2022 [3], FY2021/20/19 [4]; revenue from the Consolidated Statements of Operations [5].

The adjustment is large because SBC is large. In FY2025, stock-based compensation of $59.2M consumes 34% of reported FCF, cutting $174.9M to $115.7M [6]. More telling than any single year is the shape: adjusted FCF was negative in FY2019 through FY2022 and only crossed into positive territory in FY2023. This is a business that reached cash generation recently, not a mature cash machine that stumbled.

The yield, three ways

Yields on current market cap of $12.6B (39.3M shares at $321.19, 2026-07-31). Reported FCF and SBC per the FY2025 10-K Consolidated Statements of Cash Flows [7]; 3-yr average is adjusted FCF for FY2023–FY2025 ($82.8M).

Current adjusted yield is 0.92%. The three-year average is lower still at 0.66%, because FY2023 adjusted FCF was only $31.6M. At $321.19 the market values Penumbra at roughly 72 times reported FCF and 109 times adjusted FCF.

The company's own history rules out the fortress signature the framework hunts — a stable ~3.5–4% name suddenly repriced to 8–9%. Computing the adjusted yield on each year's then-current market cap (same-year shares at the fiscal-year-end close) shows a series that has never crossed 1.1% and was negative for four straight years:

Adjusted FCF ÷ (same-year shares × fiscal-year-end close); derived from company filings and daily prices. Shares and SBC per the 10-K cash-flow statements [8] [9].

There is no baseline to jump from. Penumbra has traded on a growth multiple its entire public life, so the adjusted yield has hovered near zero throughout — not because the business is broken, but because the price has always embedded years of forward growth. The current 0.92% is the high-water mark of a series that has never approached the reference line.

Which bar applies

The bar is set by the balance sheet. Penumbra carries no funded debt — no term loans, notes, or borrowings appear anywhere in the FY2025 10-K. Against cash and equivalents of $186.9M plus marketable investments of $357.9M ($544.8M of liquid assets), the only balance-sheet liabilities of a debt character are lease obligations totaling $219.7M (operating $196.6M, finance $23.1M) [10].

Source: FY2025 10-K Consolidated Balance Sheets [11].

Net debt is negative whether or not leases are counted: excluding leases, net cash is $544.8M; treating all lease liabilities as debt, net cash is still $325.1M. Against FY2025 EBITDA of roughly $207M (operating income $189.2M plus depreciation and amortization $17.5M), net debt / EBITDA is negative. This is a fortress balance sheet, which selects the ~8–9% reference line.

Stated in plain arithmetic: 0.92% on FY2025 adjusted FCF against the 8–9% fortress bar — about 710 to 810 bps short. Even the unadjusted reported yield of 1.39% clears none of the distance. The gap is not marginal; it is roughly an order of magnitude.

Normalized mid-cycle yield

Penumbra is a secular-growth medical-device maker, not a cyclical, so there is no depressed trough year to normalize back toward a mid-cycle mean. If anything the current-year figure understates a rising margin trajectory rather than a cyclically depressed one — but that is growth, not a cycle. To close a 700-bps gap on FY2025 revenue of $1.40B, adjusted FCF would have to be roughly 8% of sales — near $115M times eight, or over $900M — which no normalization of the current cost base supports. Under any adjacent window (using FY2024 or a 3-year average as the base), the yield lands lower, not higher. Normalization does not rescue this pillar.

The consensus check

Consensus provides free-cash-flow estimates directly (the closest available proxy; these are pre-SBC reported FCF, not the framework's adjusted basis). On the current $12.6B market cap they clear nothing:

Consensus free-cash-flow means as of 2026-08-03; approximate adjusted yield subtracts ~$60M expected SBC. Source: CapIQ estimates (data/sp/estimates.json).

Consensus forward FCF rises from $173M (FY2026) to $300M (FY2028), yet even the FY2028 figure yields only 2.38% on today's cap — and under 2% once SBC is netted out. The sell side is not scared here; it agrees Penumbra is a fast-growing, richly valued device company, and prices it accordingly. That is the opposite of the framework's strong setup, where consensus forward FCF also clears the bar and the buy side is merely fearful.

Because consensus never approaches the ~8–9% line, no mean-reversion underwrite is available. Reaching an 8% adjusted yield at the current market cap would require roughly $1.0B of adjusted FCF against the ~$115M produced in FY2025 — a near-ninefold increase — or a commensurate fall in price. The probability of the yield reaching the bar within one to three years through cash-flow growth alone is effectively nil; the mechanism does not exist on that horizon. The stock currently trades at $321.19, above its February-2025 peak, so the modest 2024–25 drawdown detailed in Dislocation has already reversed — there is no live fear discount to reprice.

FCF-to-revenue conversion

The one genuinely favorable reading is conversion, which is improving, not deteriorating. Reported FCF margin swung from negative in FY2020–FY2022 to 12.5% in FY2025; the adjusted margin reached 8.2%.

Reported and adjusted FCF ÷ revenue; derived from company filings [12] [13].

Improving conversion is a point in the durability column, examined further in Durability. But it cuts against a yield case rather than for one: rising margins on 17%-plus revenue growth are exactly what the market has already paid 72 times FCF to own. The yield fails not because the cash flow is weak or unstable, but because the price is high.